Nipah virus

The Nipah virus, a deadly pathogen with a high fatality rate (40-75%), is causing concern in Asia following recent outbreaks. In January 2026, two cases were confirmed in West Bengal, India, affecting healthcare workers, with one death reported. Simultaneously, a fatal case was confirmed in Bangladesh. These events have prompted several Asian countries to implement stricter health screening measures, particularly for travelers from India, ahead of the Lunar New Year travel rush. While Indian officials claim the outbreak in India is contained, the WHO believes the risk of international spread remains low, but is monitoring the situation. Research indicates that a Chinese drug developed by the Wuhan Institute of Virology may offer potential treatment options, as there is currently no approved vaccine or cure for Nipah virus. Australia is also closely monitoring the spread of the virus overseas.